Barclays Cuts Aspen Aerogels (NYSE:ASPN) Price Target to $3.00

Aspen Aerogels (NYSE:ASPN) had its price target lowered by Barclays from $4.00 to $3.00 in a report issued on Thursday,Benzinga reports. Barclays currently has an underweight rating on the construction company’s stock.

Other equities research analysts have also recently issued research reports about the stock. Roth Mkm lowered their price target on shares of Aspen Aerogels from $6.00 to $3.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Zacks Research raised Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 15th. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, December 29th. Canaccord Genuity Group dropped their price objective on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Finally, TD Cowen reduced their target price on shares of Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Three analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $4.25.

Aspen Aerogels Stock Down 1.5%

Shares of NYSE:ASPN opened at $3.22 on Thursday. The company has a market capitalization of $266.13 million, a PE ratio of -0.68 and a beta of 2.99. Aspen Aerogels has a 1 year low of $2.30 and a 1 year high of $9.78. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33. The business has a fifty day moving average price of $3.36 and a two-hundred day moving average price of $4.89.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings results on Wednesday, February 25th. The construction company reported ($0.34) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.07). The company had revenue of $41.34 million during the quarter, compared to analysts’ expectations of $44.25 million. Aspen Aerogels had a negative return on equity of 13.07% and a negative net margin of 143.69%.Aspen Aerogels’s quarterly revenue was down 66.4% compared to the same quarter last year. During the same period last year, the firm posted $0.14 earnings per share. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. Analysts forecast that Aspen Aerogels will post 0.17 earnings per share for the current year.

Institutional Investors Weigh In On Aspen Aerogels

Several hedge funds have recently bought and sold shares of ASPN. Raymond James Financial Inc. lifted its stake in Aspen Aerogels by 6.8% during the second quarter. Raymond James Financial Inc. now owns 26,559 shares of the construction company’s stock worth $157,000 after purchasing an additional 1,687 shares during the last quarter. Legal & General Group Plc grew its position in Aspen Aerogels by 3.6% during the second quarter. Legal & General Group Plc now owns 67,130 shares of the construction company’s stock valued at $397,000 after acquiring an additional 2,324 shares during the last quarter. Osaic Holdings Inc. raised its stake in shares of Aspen Aerogels by 29.1% during the second quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company’s stock worth $63,000 after acquiring an additional 2,390 shares in the last quarter. SBI Securities Co. Ltd. boosted its stake in shares of Aspen Aerogels by 67.3% in the 2nd quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company’s stock valued at $38,000 after purchasing an additional 2,551 shares in the last quarter. Finally, The Manufacturers Life Insurance Company boosted its stake in shares of Aspen Aerogels by 12.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 24,671 shares of the construction company’s stock valued at $146,000 after purchasing an additional 2,656 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.